A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder-论文-万方医学网

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder

导出原文传递

翻译打印收藏纠错

作者： Nasser, Azmi ^[1] ; Hull, Joseph T. ^[2] ; Chaturvedi, Soumya A. ^[3] ; Liranso, Tesfaye ; Odebo, Oyinkansola ; Kosheleff, Alisa R. ; Fry, Nicholas ; Cutler, Andrew J. ; Rubin, Jonathan ; Schwabe, Stefan ; Childress, Ann

作者单位： Supernus Pharmaceut Inc ^[1] Dept Psychiat,SUNY Upstate Med Univ ^[2] Ctr Psychiat & Behav Med Inc ^[3]

关键词 BEHAVIOR RATING INVENTORY PSYCHIATRIC-DISORDERS EXECUTIVE FUNCTION ADHD PREVALENCE VIVALAN IMPACT HYDROCHLORIDE ADOLESCENTS COMORBIDITY

发布时间 2022-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder

相似文献

相关期刊

检索历史清除